Background In malaria endemic areas, pre‐school children are at high risk of severe and
repeated malaria illness. One possible public health strategy, known as Intermittent …

Understanding the historical, temporal changes of malaria risk following control efforts in
Africa provides a unique insight into what has been and might be archived towards a long …

Malaria, a parasite vector-borne disease, is one of the most significant health threats in
tropical regions, despite the availability of individual chemoprophylaxis. Malaria …

Introduction Cotrimoxazole (CTX) has been used for half a century. It is inexpensive hence
the reason for its almost universal availability and wide clinical spectrum of use. In the last …

This paper reviews the evidence for beneficial effects of malaria chemoprophylaxis on
haematological responses, morbidity, mortality, health service utilization and rebound …

Malaria is one of the most life-threatening infectious diseases and constitutes a major health
problem, especially in Africa. Although artemisinin combination therapies remain efficacious …

Trimethoprim (TMP) is one of a large series of pyrimidine derivatives discovered by
Hitchings and his colleagues at The Wellcome Research Laboratories in the United States …

Background Malaria causes repeated illness in children living in endemic areas. Policies of
giving antimalarial drugs at regular intervals (prophylaxis or intermittent treatment) are being …

Sulfadoxine-pyrimethamine (SP) and co-trimoxazole were both effective in reducing fever,
clearing parasitaemia and improving anaemia in children aged< 5 years with uncomplicated …

Abstract In The Gambia co-trimoxazole is used widely to treat children with an acute
respiratory infection (ARI). Because malaria may sometimes be mistaken for ARI, some …